-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $137 FROM $133

Reuters·10/23/2026 10:48:09

Please log in to view news